Increased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell

References

• Agullo-Ortuno MT, Diaz-Garcia CV, Agudo-Lopez A, Perez C, Cortijo A, Paz-Ares L, Lopez Martin JA. 2015. Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer. J Cancer Res Clin Oncol 141:43–53
   PubMed Web of Science ®Google Scholar
• Ahlen J, Wejde J, Brosjo O, von Rosen A, Weng WH, Girnita L, Larsson C. 2005. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma. Clin Cancer Res 11:206–216
   PubMed Web of Science ®Google Scholar
• All-Ericsson C, Girnita L, Seregard S, Bartolazzi A, Jager MJ, Larsson O. 2002. Insulin-like growth factor-1 receptor in uveal melanoma: A predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci 43:1–8
   PubMed Web of Science ®Google Scholar
• Badzio A, Wynes MW, Dziadziuszko R, Merrick DT, Pardo M, Rzyman W, Hirsch FR. 2010. Increased insulin-like growth factor 1 receptor protein expression and gene copy number in small cell lung cancer. J Thorac Oncol 5:1905–1911
   PubMed Web of Science ®Google Scholar
• Baserga R. 1999. The IGF-I receptor in cancer research. Exp Cell Res 253:1–6
   PubMed Web of Science ®Google Scholar
• Bohula EA, Playford MP, Macaulay VM. 2003. Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment. Anticancer Drugs 14:669–682
   PubMed Web of Science ®Google Scholar
• Brahmkhatri VP, Prasanna C, Atreya HS. 2015. Insulin-like growth factor system in cancer: Novel targeted therapies. Biomed Res Int 2015:538019
   PubMed Web of Science ®Google Scholar
• Brodt P, Fallavollita L, Khatib AM, Samani AA, Zhang D. 2001. Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit. J Biol Chem 276:33608–33615
   PubMed Web of Science ®Google Scholar
• Camirand A, Pollak M. 2004. Co-targeting IGF-1R and c-kit: Synergistic inhibition of proliferation and induction of apoptosis in H 209 small cell lung cancer cells. Br J Cancer 90:1825–1829
   PubMed Web of Science ®Google Scholar
• Chang MH, Lee J, Han J, Park YH, Ahn JS, Park K, Ahn MJ. 2009. Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer. APMIS 117:861–869
   PubMed Web of Science ®Google Scholar
• Chin YR, Toker A. 2009. Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. Cell Signal 21:470–476
   PubMed Web of Science ®Google Scholar
• Chong KY, Subramanian A, Mokbel K, Sharma AK. 2011. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue. J Surg Oncol 104:228–235
   PubMed Web of Science ®Google Scholar
• Dupont J, Pierre A, Froment P, Moreau C. 2003. The insulin-like growth factor axis in cell cycle progression. Horm Metab Res 35:740–750
   PubMed Web of Science ®Google Scholar
• Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R. 2008. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 114:23–37
   PubMedGoogle Scholar
• Ferla J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Bray F, et al. 2015. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386
   PubMed Web of Science ®Google Scholar
• Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M. 2004. PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30:193–204
   PubMed Web of Science ®Google Scholar
• Fruh M, De Ruysscher D, Popat S, Crino L, Peters S, Felip E. 2013. Small-cell lung cancer (SCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24:99–105
   Web of Science ®Google Scholar
• Garcia-Echeverria C, Sellers WR. 2008. Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene 27:5511–5526
   PubMed Web of Science ®Google Scholar
• Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, Piccirillo J. 2006. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24:4539–4544
   PubMed Web of Science ®Google Scholar
• Kang GH, Lee BS, Lee ES, Kim SH, Lee HY, Kang DY. 2014. Prognostic significance of p53, mTOR, c-Met, IGF-1R, and HSP70 overexpression after the resection of hepatocellular carcinoma. Gut Liver 8:79–87
   PubMed Web of Science ®Google Scholar
• Karp DD, Paz-Ares LG, Novello S, Haluska P, Garland L, Cardenal F, Gualberto A. 2009. Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. J Clin Oncol 27:2516–2522
   PubMed Web of Science ®Google Scholar
• Kim YH, Sumiyoshi S, Hashimoto S, Masago K, Togashi Y, Sakamori Y, Mishima M. 2012. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer. Clin Lung Cancer 13:385–390
   PubMed Web of Science ®Google Scholar
• Lababede O, Meziane M, Rice T. 2011. Seventh edition of the cancer staging manual and stage grouping of lung cancer: Quick reference chart and diagrams. Chest 139:183–189
   PubMed Web of Science ®Google Scholar
• Langer CJ, Novello S, Park K, Krzakowski M, Karp DD, Mok T, Jassem J. 2014. Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer. J Clin Oncol 32:2059–2066
   PubMed Web of Science ®Google Scholar
• LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. 1995. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143–163
   PubMed Web of Science ®Google Scholar
• Li S, Ferber A, Miura M, Baserga R. 1994. Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain. J Biol Chem 269:32558–32564
   PubMed Web of Science ®Google Scholar
• Macaulay VM. 2004. The IGF receptor as anticancer treatment target. Novartis Found Symp 262:235–243; discussion 243–236, 265–238
   PubMedGoogle Scholar
• Nakanishi Y, Mulshine JL, Kasprzyk PG, Natale RB, Maneckjee R, Avis I, Cuttitta F. 1988. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest 82:354–359
   PubMed Web of Science ®Google Scholar
• Ozkan EE. 2011. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review. Mol Cell Endocrinol 344:1–24
   PubMed Web of Science ®Google Scholar
• Pavelic J, Matijevic T, Knezevic J. 2007. Biological & physiological aspects of action of insulin-like growth factor peptide family. Indian J Med Res 125:511–522
   PubMed Web of Science ®Google Scholar
• Pollak M. 2008. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8:915–928
   PubMed Web of Science ®Google Scholar
• Resnik JL, Reichart DB, Huey K, Webster NJ, Seely BL. 1998. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Cancer Res 58:1159–1164
   PubMed Web of Science ®Google Scholar
• Schabath MB, Nguyen A, Wilson P, Sommerer KR, Thompson ZJ, Chiappori AA. 2014. Temporal trends from 1986 to 2008 in overall survival of small cell lung cancer patients. Lung Cancer 86:14–21
   PubMed Web of Science ®Google Scholar
• Sepp-Lorenzino L. 1998. Structure and function of the insulin-like growth factor I receptor. Breast Cancer Res Treat 47:235–253
   PubMed Web of Science ®Google Scholar
• Singh P, Alex JM, Bast F. 2014. Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: Novel treatment strategies for cancer. Med Oncol 31:805
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Ito F. 2011. Receptor tyrosine kinases and targeted cancer therapeutics. Biol Pharm Bull 34:1774–1780
   PubMed Web of Science ®Google Scholar
• van Meerbeeck JP, Fennell DA, De Ruysscher DK. 2011. Small-cell lung cancer. Lancet 378:1741–1755
   PubMed Web of Science ®Google Scholar
• White MF. 2003. Insulin signaling in health and disease. Science 302:1710–1711
   PubMed Web of Science ®Google Scholar
• Zhang D, Brodt P. 2003. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling. Oncogene 22:974–982
   PubMed Web of Science ®Google Scholar
• Zhang R, Xu GL, Li Y, He LJ, Chen LM, Wang GB, Shan HB. 2013. The role of insulin-like growth factor 1 and its receptor in the formation and development of colorectal carcinoma. J Int Med Res 41:1228–1235
   PubMed Web of Science ®Google Scholar